2020
Trends in Use and Comparison of Stereotactic Body Radiation Therapy, Brachytherapy, and Dose-Escalated External Beam Radiation Therapy for the Management of Localized, Intermediate-Risk Prostate Cancer
Nguyen KA, Lee A, Patel SA, Chakravorty A, Yu JB, Kishan AU, Chang AJ. Trends in Use and Comparison of Stereotactic Body Radiation Therapy, Brachytherapy, and Dose-Escalated External Beam Radiation Therapy for the Management of Localized, Intermediate-Risk Prostate Cancer. JAMA Network Open 2020, 3: e2017144. PMID: 32970153, PMCID: PMC7516602, DOI: 10.1001/jamanetworkopen.2020.17144.Peer-Reviewed Original ResearchConceptsStereotactic body radiation therapyBody radiation therapyRadiation therapyProstate cancerIntermediate-risk prostate cancerExternal beam radiation therapyManagement of LocalizedExternal beam radiotherapyUse of brachytherapyBeam radiation therapyCohort studyBeam radiotherapyTherapyDisease managementCancerBrachytherapyPatientsRadiotherapy
2016
Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer
Lester-Coll N, Johnson S, Magnuson W, Goldhaber S, Sher D, D'Amico A, Yu J. Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer. Journal Of The National Cancer Institute 2016, 109: djw281. PMID: 28040795, DOI: 10.1093/jnci/djw281.Peer-Reviewed Original ResearchConceptsIntermediate-risk prostate cancerQuality-adjusted life yearsHormone therapyHistory of myocardial infarctionCardiac risk factorsBiochemical failureProstate cancerRadiation therapyCardiac riskProbability of biochemical failureMonths of hormone therapyRisk factorsMyocardial infarctionYears of follow-upBenefits of HTRisk of cardiovascular mortalityDisease recurrence riskCardiac risk groupsComparing quality-adjusted life-yearsYoung menRecurrence riskFollow-upRisk groupsCardiovascular mortalityLow riskImpact of Concurrent Androgen-Deprivation Therapy and Radiation Therapy Versus Radiation Therapy Alone on Overall Survival for Men With Unfavorable Intermediate-Risk Prostate Cancer
Johnson S, Lester-Coll N, Stahl J, Nath S, Yu J. Impact of Concurrent Androgen-Deprivation Therapy and Radiation Therapy Versus Radiation Therapy Alone on Overall Survival for Men With Unfavorable Intermediate-Risk Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e240. DOI: 10.1016/j.ijrobp.2016.06.1227.Peer-Reviewed Original ResearchAssessing Potential Cardiovascular Risk Against the Benefits of Hormonal Therapy in Men With Intermediate-Risk Prostate Cancer
Lester-Coll N, Johnson S, Magnuson W, Yu J. Assessing Potential Cardiovascular Risk Against the Benefits of Hormonal Therapy in Men With Intermediate-Risk Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: s140. DOI: 10.1016/j.ijrobp.2016.06.340.Peer-Reviewed Original Research